APRIL knockdown suppresses migration and invasion of human colon carcinoma cells

Clinical Biochemistry

Volumn 42, Issue 16-17, 2009, Pages 1694-1698

  Ding, Weifeng ^a   Wang, Jinchun ^a   Sun, Baolan ^a   Ju, Shaoqing ^a   Yuan, Hongxiang ^a   Wang, Xing ^b   Wang, Yueguo ^a   Wang, Huimin ^a  

^a NANTONG UNIVERSITY   (China)

^b Putuo District People Hospital ^*  (China)

Author keywords

APRIL; Colorectal neoplasms; Invasion; Migration; RNAi

Indexed keywords

APRIL PROTEIN; RNA;

ARTICLE; CARCINOMA CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; KNOCKOUT GENE; PRIORITY JOURNAL; RNA INTERFERENCE;

BLOTTING, WESTERN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 70349765559     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.06.019     Document Type: Article

References (26)

1. Sotsky T.K., and Ravikumar T.S. Cryotherapy in the treatment of liver metastases from colorectal cancer. Semin. Oncol. 29 (2002) 183-191
2. Cheadle E.J., Riyad K., Subar D., et al. Eotaxin-2 and colorectal cancer: a potential target for immune therapy. Clin. Cancer Res. 13 (2007) 5719-5728
3. Hahne M., Kataoka T., Schroter M., et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 188 (1998) 1185-1190
4. Mackay F., Schneider P., Rennert P., and Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 21 (2003) 231-264
5. Roschke V., Sosnovtseva S., Ward C.D., et al. BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases. J. Immunol. 169 (2002) 4314-4321
6. Nishio M., Endo T., Tsukada N., et al. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 106 (2005) 1012-1020
7. Mongini P.K., Inman J.K., Han H., Fattah R.J., Abramson S.B., and Attur M. APRIL and BAFF promote increased viability of replicating human B2 cells via mechanism involving cyclooxygenase 2. J. Immunol. 176 (2006) 6736-6751
8. Tangye S.G., Bryant V.L., Cuss A.K., and Good K.L. BAFF, APRIL and human B cell disorders. Semin. Immunol. 18 (2006) 305-317
9. Endo T., Nishio M., Enzler T., et al. BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappa B pathway. Blood 109 (2006) 703-710
10. Pradet-Balade B., Medema J.P., Lopez-Fraqa M., et al. An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. EMBO J. 21 (2002) 5711-5720
11. Dillon S.R., Gross J.A., Ansell S.M., and Novak A.J. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat. Rev. Drug Discov. 5 (2006) 235-246
12. Deshayes F., Lapre'e G., Portier A., et al. Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor. Oncogene 23 (2004) 3005-3012
13. Rennert P., Schneider P., Cachero T.G., et al. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J. Exp. Med. 192 (2000) 1677-1684
14. Marsters S.A., Yan M., Pitti R.M., Haas P.E., Dixit V.M., and Ashkenazi A. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI. Curr. Biol. 10 (2000) 785-788
15. Wu Y., Bressette D., Carrell J.A., et al. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS. J. Biol. Chem. 275 (2000) 35478-35485
16. Roth W., Wagenknecht B., Klumpp A., et al. APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis. Cell Death Differ. 8 (2001) 403-410
17. Hendriks J., Planelles L., de Jong-Odding J., et al. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ. 12 (2005) 637-648
18. Ingold K., Zumsteg A., Tardivel A., et al. Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 201 (2005) 1375-1383
19. Kam Y., Guess C., Estrada L., Weidow B., and Quaranta V. A novel circular invasion assay mimics in vivo invasive behavior of cancer cell lines and distinguishes single-cell motility in vitro. BMC cancer 8 (2008) 198
20. Okano H., Shiraki K., Yamanaka Y., et al. Functional expression of a proliferation-related ligand in hepatocellular carcinoma and its implications for neovascularization. World J. Gastroenterol. 11 (2005) 4650-4654
21. Hannon G.J. RNA interference. Nature 418 (2002) 244-251
22. Esko J.D., and Lindahl U. Molecular diversity of heparan sulfate. J. Clin. Invest. 108 (2001) 169-173
23. Gallagher J.T. Heparan sulfate: growth control with a restricted sequence menu. J. Clin. Invest. 108 (2001) 357-361
24. Perrimon N., and Bernfield M. Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404 (2000) 725-728
25. Hayashida K., Johnston D.R., Goldberger O., and Park P.W. Syndecan-1 expression in epithelial cells is induced by transforming growth factor beta through a PKA-dependent pathway. J. Biol. Chem. 281 (2006) 24365-24374
26. Vincent T., and Mechti N. IL-6 regulates CD44 cell surface expression on human myeloma cells. Leukemia 18 (2004) 967-975